• 1
    Korbet SM. Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 1998; 50: 13331340.
  • 2
    Cameron JS. Recurrent renal disease after renal transplantation. Curr Opin Nephrol Hypertens 1994; 3: 602607.
  • 3
    Dall'Amico R, Ghiggeri G, Carraro M, Artero M et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 1999; 34: 104855.
  • 4
    Kim EM, Striegel J, Kim Y, Matas AJ, Najarian JS, Mauer SM. Recurrence of steroid-resistant nephritic syndrome is associated with increased acute renal failure and acute rejection. Kidney Int 1994; 45: 14401445.
  • 5
    Baum MA, Stablein DM, Panzarino et al. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001; 59: 328333.
  • 6
    Briggs JD, Jones E, on behalf of the scientific advisory board of the ERA-EDTA Registry. Recurrence of glomerulonephritis following renal transplantation. Nephrol Dial Transplant 1999; 14: 564565.
  • 7
    Holgado R, Del Castillo D, Mazuecos A et al. Long-term outcome of focal segmental glomerulosclerosis after renal transplantation. Transplant Proc 1999; 31: 23042305.
  • 8
    Dantal J, Baatard R, Hourmant M et al. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis: A one-center study of plasma exchange effects. Transplantation 1991; 52: 827831.
  • 9
    Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduced proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994; 23: 574581.
  • 10
    Carraro M, Caridi G, Bruschi M et al. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2002; 13(7): 19461952.
  • 11
    Cheigh JS, Mouradian J, Susin M et al. Kidney transplant nephrotic syndrome: Relationship between allograft histopathology and natural course. Kidney Int 1980; 18: 358365.
  • 12
    Pinto J, Lacerda G, Cameron JS et al. Recurrence of focal and segmenal glomerulosclerosis in renal allografts. Transplantation 1932; 32: 8389.
  • 13
    Tejani A, Stablein DH. Recurrence of focal and segmental glomerulosclerosis posttransplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992; 2(Suppl 12): S258263.
  • 14
    Lewis EJ. Recurrent focal sclerosis after renal transplantation. Kidney Int 1982; 22: 315323.
  • 15
    Abbott KC, Sawyers ES, Oliver JD et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001; 37: 366373.
  • 16
    Striegel JE, Sibley RK, Fryd DS, Mauer SM. Recurrence of focal segmental sclerosis in children following renal transplantation. Kidney Int Suppl 1986; 19: S4450.
  • 17
    Briganti EM, Russ GR, McNeil JJ et al. Risk of renal allograft loss from recurrent glomerulonephritis. New Eng J Med 2002; 347: 103109.
  • 18
    Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: Natural history and response to therapy. Am J Med 1992; 92: 375383.
  • 19
    Dantal J, Bigot E, Bogers W et al. Effect of plasma protein adsorption on protein excretion in kidney transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994; 330: 714.
  • 20
    Dantal J, Godfrin Y, Koll R et al. Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 1998; 9: 17091715.
  • 21
    Savin VJ, Artero M, Sharma R et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878883.
  • 22
    Sharma M, Sharma R, McCarthy ET, Savin VJ. The focal segmental glomerulosclerosis permeability factor: Biochemical characteristics and biological effects. Exp Biol Med (Maywood) 2004; 229: 8598.
  • 23
    Sharma R, Sharma M, McCarthy ET, Ge XL, Savin VJ. Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro. Kidney Int 2000; 58(5): 19731979.
  • 24
    Candiano G, Musante L, Carraro M et al. Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental sclerosis. J Am Soc Nephrol 2001; 12(1): 143150.
  • 25
    Savin VJ, Sharma R, Lovell HB, Welling DJ. Measurement of albumin reflection coefficient in isolated rat glomeruli. J Am Soc Nephrol 1992; 3: 12601269.
  • 26
    Savin VJ, Artero M, Sharma R et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878883.
  • 27
    Ohta T, Kawaguchi H, Hattori M et al. Effect of pre- and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 2001; 71: 628633.
  • 28
    Savin VJ, McCarthy ET, Sharma M. Permeability factor in FSGS. Semin Nephrol 2003; 23: 147160.
  • 29
    Haas M, Godfrin Y, Oberbauer R et al. Plasma immunoadsorption treatment in patients with primary focal and segmental glomerulosclerosis. Nephrol Dial Transplant 1998; 13: 20132016.
  • 30
    Andresdottir MB, Ajubi N, Croockewit S, Assmann KJ, Hibrands LB, Wetzels JF. Recurrent focal glomerulosclerosis: Natural course and treatment with plasma exchange. Nephrol Dial Transplant 1999; 14: 26502656.
  • 31
    Mowry JA, McCarthy ET. Cyclosporine in glomerular disease. Sem Nephrol 1996; 16: 548554.
  • 32
    Banfi G, Colturi C, Montagnino G, Ponticelli C. The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine. Transplantation 1990; 50: 594596.
  • 33
    Sharma R, Savin VJ. Cyclosporine prevents the increase of glomerular albumin permeability caused by serum from patients with focal segmental glomerulosclerosis. Transplantation 1996; 61: 381383.
  • 34
    Vincenti F, Biava C, Tomlanovitch S et al. Inability of cyclosporine to completely prevent the recurrence of focal glomerulosclerosis after kidney transplantation. Transplantation 1989; 47: 595598.
  • 35
    Kershaw DB, Sedman AB, Kelsch RC, Bunchman TE. Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: Successful treatment with oral cyclophosphamide. Clin Transplant. 1994; 8(6): 546549.